Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax

Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax

Covishield-maker Serum Institute to begin trial of second Covid-19 vaccine Covovax: In a tweet, Adar Poonawalla said, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!”
Check the source here –Source, Financial Express.

Change Language